Consortium Québécois sur la découverte du médicament
Quebeccqdm.org
Overview
CQDM is a non-profit biopharmaceutical research consortium whose mission is to support and facilitate multi-stakeholder collaborative R&D that accelerates translation of leading-edge discoveries into vaccines, therapeutics and diagnostics addressing unmet medical needs while generating significant benefits for the Canadian economy. CQDM deploys R&D funding programs that focus on accelerating the translation of innovation into socio-economic outcomes and health benefits for our population.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| MISO Chip | Jul 2026 | Grant | Co-investor |
| DropGenie | Jun 2026 | Seed | Co-investor |
| TATUM Bioscience | Jun 2026 | Grant | Co-investor |
| RIME Therapeutics | Apr 2026 | Seed | Co-investor |
| Whelix | Mar 2026 | Accelerator | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.